Biechele Royce Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $6.76M | Sell |
|
|||||
|
2023
Q1 | $7.93M | Sell |
|
|||||
|
2022
Q4 | $8.6M | Sell |
|
|||||
|
2022
Q3 | $8.9M | Sell |
|
|||||
|
2022
Q2 | $10.5M | Sell |
|
|||||
|
2022
Q1 | $10.3M | Sell |
|
|||||
|
2021
Q4 | $8.94M | Buy |
|
|||||
|
2021
Q3 | $8.14M | Buy |
|
|||||
|
2021
Q2 | $8.95M | Buy |
|
|||||
|
2021
Q1 | $8.13M | Buy |
|
|||||
|
2020
Q4 | $3.36M | Sell |
|
|||||
|
2020
Q3 | $3.29M | Sell |
|
|||||
|
2020
Q2 | $3.3M | Sell |
|
|||||
|
2020
Q1 | $3.16M | Sell |
|
|||||
|
2019
Q4 | $3.84M | Sell |
|
|||||
|
2019
Q3 | $3.09M | Buy |
|
|||||
|
2019
Q2 | $2.63M | Buy |
|
|||||
|
2019
Q1 | $2.62M | Buy |
|
|||||
|
2018
Q4 | $2.73M | Sell |
|
|||||
|
2018
Q3 | $3.29M | Sell |
|
|||||
|
2018
Q2 | $5.45M | Buy |
|
|||||
|
2018
Q1 | $5.74M | Buy |
|
|||||
|
2017
Q4 | $5.5M | Buy |
|